An avian flu vaccine contract with Moderna may be suspended, pending review of the contract by the current administration, according to a recent Reuters news story. The vaccine contract was awarded to ...

As summer approaches, infectious diseases such as H5N1 — commonly known as bird flu — can spread more easily and potentially ...

NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) announced receipt of key guidance from the U.S. Food and Drug Administration (FDA) regarding the development of its investigational antiviral, tivoxavir ...

The Department of Health and Human Service is pulling millions of dollars in funding for a human bird flu vaccine developed by Covid vaccine-maker Moderna. "While the termination of funding from HHS ...

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.

The U.S. government is pulling its funding for drugmaker Moderna to continue testing an mRNA vaccine intended to protect people from the bird flu. The move comes after Health Secretary Robert F.

Amid fears of a bird flu pandemic in humans owing to the unprecedented rise in bird flu cases this year, the federal government has intensified its efforts in the development of new vaccines, ...

Novel, potent pan-viral inhibitors targeting the viral replication complex are under development for the treatment of ...

The Department of Health and Human Services is canceling the development of 22 mRNA vaccines, citing a lack of efficacy for preventing respiratory viruses like the flu and COVID-19. The department ...

In most people, influenza stays in the upper respiratory tract—mainly the nose—and clears without spreading further. But ...

Seasonal influenza can spread rapidly, and timely information on rising cases is essential for public health decisions and ...